Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Adenocarcinoma × Methadone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 10 Neoplasms 7 Cancer Pain 5 Pain, Postoperative 2 Pain, Intractable 2 Lymphoma, Follicular 2 Leukemia 2 Waldenstrom Macroglobulinemia 1 Vomiting 1 Urinary Bladder Neoplasms 1 Thrombocythemia, Essential 1 Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1 Spinal Surgery 1 Sleep Wake Disorders 1 Signs and Symptoms 1 Sezary Syndrome 1 Rectal Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Postoperative Complications 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pathologic Processes 1 Pain Related to Cancer 1 Opioid-Related Disorders 1 Neurologic Manifestations 1 Neoplasms, Plasma Cell 1 Nausea 1

Interventions

Oxaliplatin 42 Gemcitabine 41 Fluorouracil 37 Capecitabine 29 pembrolizumab 28 Leucovorin 26 Docetaxel 25 Cisplatin 24 Paclitaxel 21 Carboplatin 18 Bevacizumab 17 Irinotecan 16 130-nm albumin-bound paclitaxel 16 Pemetrexed 15 Radiotherapy 13 Albumin-Bound Paclitaxel 13 Nivolumab 12 Cyclophosphamide 10 Ramucirumab 9 Trastuzumab 7 Radiosurgery 7 cemiplimab 6 Taxes 6 Erlotinib Hydrochloride 6 Drug Therapy 6 zolbetuximab 5 trastuzumab deruxtecan 5 durvalumab 5 Sorafenib 5 S 1 (combination) 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05325164 2022-12-05

METHADOPT

Ottawa Hospital Research Institute

Phase 3 Withdrawn

Cancer Pain, Adenocarcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡